
LRMR Earnings Date: Nov 5, 2026 (Estimated) — Larimar Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is LRMR's next earnings date?
Larimar Therapeutics, Inc. (LRMR) is expected to report earnings on Thursday, November 5, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.35.
How did LRMR do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), Larimar Therapeutics, Inc. posted EPS of -$0.30 versus the -$0.38 estimate, a beat of 21.1%. Revenue was $0. The stock's 1-day post-earnings move was +3.3%.
How much does LRMR stock move after earnings?
LRMR beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 8.7% (up or down) in the day after earnings.
About Larimar Therapeutics, Inc.
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | -0.38 | -0.30 | +21.05% | $0 | ✅ Beat | +3.27% | +0.75% | -1.00% |
| 2026-05-14 | Q1 2026 | -0.56 | -0.31 | +44.64% | $0 | ✅ Beat | -5.12% | -13.90% | -15.37% |
| 2026-03-19 | Q4 2025 | -0.50 | -0.73 | -46.00% | $0 | ❌ Miss | +3.95% | +8.84% | +11.63% |
| 2025-11-05 | Q3 2025 | -0.41 | -0.61 | -48.78% | $0 | ❌ Miss | -15.26% | -4.47% | -3.16% |
| 2025-08-14 | Q2 2025 | -0.48 | -0.41 | +14.58% | $0 | ✅ Beat | +14.52% | +1.34% | +5.65% |
| 2025-04-30 | Q1 2025 | -0.41 | -0.46 | -12.20% | $0 | ❌ Miss | +10.88% | -12.13% | -3.77% |
| 2025-03-24 | Q4 2024 | -0.32 | -0.45 | -40.62% | $0 | ❌ Miss | -10.24% | -7.48% | -6.30% |
| 2024-08-07 | Q2 2024 | -0.30 | -0.34 | -13.33% | $0 | ❌ Miss | -6.54% | -1.05% | +16.34% |
Showing last 8 quarters.